These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 22126240)

  • 21. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
    Yang X; Ferguson AT; Nass SJ; Phillips DL; Butash KA; Wang SM; Herman JG; Davidson NE
    Cancer Res; 2000 Dec; 60(24):6890-4. PubMed ID: 11156387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter.
    Strunnikova M; Schagdarsurengin U; Kehlen A; Garbe JC; Stampfer MR; Dammann R
    Mol Cell Biol; 2005 May; 25(10):3923-33. PubMed ID: 15870267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
    Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
    Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Momentum building for human epigenome project.
    Garber K
    J Natl Cancer Inst; 2006 Jan; 98(2):84-6. PubMed ID: 16418505
    [No Abstract]   [Full Text] [Related]  

  • 25. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer.
    Leu YW; Yan PS; Fan M; Jin VX; Liu JC; Curran EM; Welshons WV; Wei SH; Davuluri RV; Plass C; Nephew KP; Huang TH
    Cancer Res; 2004 Nov; 64(22):8184-92. PubMed ID: 15548683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
    Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
    Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
    Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
    Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
    Kim JH; Kang HS; Kim TW; Kim SJ
    Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-estrogens in the treatment of breast cancer: current status and future directions.
    Barker S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):652-7. PubMed ID: 12901222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer.
    Nass SJ; Herman JG; Gabrielson E; Iversen PW; Parl FF; Davidson NE; Graff JR
    Cancer Res; 2000 Aug; 60(16):4346-8. PubMed ID: 10969774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
    Malley DS; Hamoudi RA; Kocialkowski S; Pearson DM; Collins VP; Ichimura K
    Acta Neuropathol; 2011 May; 121(5):651-61. PubMed ID: 21287394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.
    Shah R; Smith P; Purdie C; Quinlan P; Baker L; Aman P; Thompson AM; Crook T
    Br J Cancer; 2009 May; 100(10):1687-96. PubMed ID: 19436308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetics].
    Tabe Y
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():86-90. PubMed ID: 23133933
    [No Abstract]   [Full Text] [Related]  

  • 35. Conference Scene: Omic technologies in human disease: extending the network of epigenetic control.
    Schnekenburger M; Diederich M
    Epigenomics; 2011 Oct; 3(5):539-41. PubMed ID: 22126244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetics and breast cancer.
    Asch BB; Barcellos-Hoff MH
    J Mammary Gland Biol Neoplasia; 2001 Apr; 6(2):151-2. PubMed ID: 11501575
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeted functional imaging in breast cancer.
    Kumar R
    Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):346-53. PubMed ID: 17404770
    [No Abstract]   [Full Text] [Related]  

  • 38. [DNA methylation and cancer].
    Yu L
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):403-4. PubMed ID: 16008842
    [No Abstract]   [Full Text] [Related]  

  • 39. Heart disease linked to oestrogen-receptor gene methylation.
    Fricker J
    Mol Med Today; 1999 Dec; 5(12):505-6. PubMed ID: 10562714
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence that DNA methylation engenders dynamic gene regulation.
    Wilkinson MF
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2116. PubMed ID: 25848065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.